458 | OPTIMIZING POST–CHIMERIC ANTIGEN RECEPTOR T CELL MONITORING: EVIDENCE ACROSS LISOCABTAGENE MARALEUCEL PIVOTAL CLINICAL TRIALS AND REAL‐WORLD EXPERIENCEM. Kamdar, Matthew A. Lunning, M. Shadman et al.|Hematological Oncology|2025Cited by 0